EconPapers    
Economics at your fingertips  
 

Research Progress of Chinese and Western Medicine in Treatment of Rheumatoid Arthritis

Guifu Tian and Zhibin Li
Additional contact information
Guifu Tian: Graduate Student of Class 2021, Shaanxi University of Chinese Medicine, Xianyang 712046, China
Zhibin Li: Joint Ward, Bone Injury Hospital, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China

Journal of Innovations in Medical Research, 2023, vol. 2, issue 1, 11-18

Abstract: At present, the etiology of rheumatoid arthritis (RA) is not clear, and its pathogenesis has not been clarified. For this, in clinic can only make corresponding treatment for the onset period and sequelae of the disease. Through reviewing relevant literature in recent years, it is found that the combined use of traditional Chinese and western medicine has great advantages in the treatment of rheumatoid arthritis. This paper will analyze and summarize the current treatment status and medication rules of traditional Chinese and western medicine for rheumatoid arthritis, hoping to provide reference for clinical treatment plans, so as to further improve clinical efficacy and improve treatment plans.

Keywords: rheumatoid arthritis; pathogenesis; medication; clinical effect (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.paradigmpress.org/jimr/article/view/402/351 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bdz:joimer:v:2:y:2023:i:1:p:11-18

DOI: 10.56397/JIMR/2023.01.03

Access Statistics for this article

More articles in Journal of Innovations in Medical Research from Paradigm Academic Press
Bibliographic data for series maintained by Editorial Office ().

 
Page updated 2026-05-29
Handle: RePEc:bdz:joimer:v:2:y:2023:i:1:p:11-18